Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Activating ER-β, not ER-α, improves skin cell growth and wound healing.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

Recent advances in hair loss treatments show significant progress.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Dopamine stops hair growth and pigment production in human scalp hair follicles.

Finasteride reduces movement issues in Parkinson's disease rats.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

New cell-based therapies may improve hair loss treatments in the future.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The conclusion is that metformin is a first-line treatment for PCOS, particularly for restoring ovulation and increasing pregnancy rates, with other treatments depending on specific symptoms.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.